Istituto di Candiolo, IRCCS

Candiolo, Torino 10060

0 studies enrolling now · 2 studies all time

What they study most

Carcinoma, Renal Cell, HER-2 Positive Breast Cancer, Metastatic Neoplasm

Studies at this site

• Margetuximab Plus Chemotherapy vs Trastuzumab Plus Chemotherapy in the Treatment of HER2+ Metastatic Breast Cancer — Completed
• A Study to Compare Tivozanib Hydrochloride to Sorafenib in Participants With Refractory Advanced Renal Cell Carcinoma (RCC) — Completed